The dual-label lateral flow assay discriminated ascites samples from cancer patients and liver cirrhosis controls, with LOD for CA125-STn at 1.8 U/ml in buffer and 3.6 U/ml in ascites, and a linear range of 1-2500 U/ml 257. This evidence concerns the gene MUC16 and cancer.